Bioanalytical Systems (NASDAQ:BASI) will post its quarterly earnings results before the market opens on Thursday, February 14th.
Bioanalytical Systems (NASDAQ:BASI) last released its earnings results on Thursday, December 20th. The company reported $0.01 earnings per share for the quarter. The firm had revenue of $8.99 million for the quarter. Bioanalytical Systems had a negative net margin of 0.74% and a positive return on equity of 2.89%.
BASI opened at $1.43 on Wednesday. The stock has a market capitalization of $14.08 million, a price-to-earnings ratio of 72.00 and a beta of 0.78. The company has a debt-to-equity ratio of 0.79, a quick ratio of 0.58 and a current ratio of 0.68. Bioanalytical Systems has a twelve month low of $1.18 and a twelve month high of $2.59.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.com-unik.info/2019/02/13/bioanalytical-systems-basi-to-release-earnings-on-thursday.html.
Bioanalytical Systems, Inc provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products.
Featured Article: Cost of Equity For A Business, Investors
Receive News & Ratings for Bioanalytical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioanalytical Systems and related companies with MarketBeat.com's FREE daily email newsletter.